GOSIA GENOMICS
LIVE

Serial Number

99520613

Owner

Gosia Genomics Inc

First Use Date

Jul 26, 2025

Filing Date

Nov 28, 2025

Add to watchlist:

No watchlists yet
View on USPTO

GOSIA GENOMICS Trademark

Serial Number: 99520613

GOSIA GENOMICS is a trademark filed by Gosia Genomics Inc on November 28, 2025. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Gosia Genomics Inc

78 John Miller Way, Suite #326
Kearny, NJ 07032

Entity Type: 03

Trademark Details

Filing Date

November 28, 2025

Registration Date

Not Registered

First Use Anywhere

July 26, 2025

First Use in Commerce

July 27, 2025

Goods & Services

(Based on Use) Genomic testing and analyses services for wellness, diagnostic, and predisposition testing specifically focused on women's health, including gynecological and menstrual health, reproductive health, fertility, menopause, maternal and pregnancy health, skin care, diet, sleep, and fitness; General genomic testing and analyses services for wellness, diagnostic, longevity, and predisposition testing for gut health, nutrition, diet, weight loss, food intolerance, fitness, skin care, dermatology, medical aesthetics, pharmacogenomics, and cognitive health; (Based on Intent to Use) Health coaching and nutrition counseling services for general health and lifestyle wellness, with a specific focus on women's health, including gynecological, menstrual, reproductive, peri-menopause, menopause, post-menopause, maternal, and pregnancy health; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories, including hormone level testing services

Online retail store services featuring DNA collection kits and health and wellness analysis services

Software as a service (SAAS) services featuring non-downloadable software using artificial intelligence (AI) specifically focused on women's health, general health and wellness, diagnosis, and predisposition risk assessment, which includes the analysis, interpretation, reporting, knowledge portal, patient monitoring, and personalized recommendations based on genomic data, and may include other laboratory test results; Scientific research in the fields of women's health, general wellness, genomics, and artificial intelligence (AI)

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 12, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 12, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 13, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 13, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 13, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 1, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 26, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Nov 28, 2025 MAFR
NEW APPLICATION ENTERED
Nov 28, 2025 NWAP